30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Lixte Biotechnology Holdings Inc (LIXT)

Track

The most recent insider trading activity occurred on October 3, 2023, with a BUY transaction by the President and CEO. Prior to this, significant BUY transactions were observed in late 2022 by various executives, including the President and CEO and the Vice President and COO. The total number of insider transactions in the last 90 days is zero.
Stock chart
Ticker: LIXT Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
van der Baan Bastiaan Jeroen
President and CEO
1 purchase — total 28,000 USD
Buy 3 Oct 2023
Value US$1,019,664.98 | Price 452.20 | Shares 37,939
Buy 30 Dec 2022
Value US$4,387,821.83 | Price 390.08 | Shares 14,771
Buy 15 Dec 2022
Value US$7,650.00 | Price 0.51 | Shares 15,000
Buy 12 Dec 2022
Value US$6,100.00 | Price 0.61 | Shares 10,000
Buy 22 Nov 2022
Value US$1,391.04 | Price 0.56 | Shares 2,484
Buy 21 Nov 2022
Value US$815.92 | Price 0.56 | Shares 1,457
Buy 21 Nov 2022
Value US$1,508.00 | Price 0.58 | Shares 2,600
Buy 21 Nov 2022
Value US$1,368.00 | Price 0.57 | Shares 2,400
Buy 18 Nov 2022
Value US$3,388.80 | Price 0.56 | Shares 6,059
Buy 18 Nov 2022
Value US$1,399.75 | Price 0.56 | Shares 2,500
Buy 18 Nov 2022
Value US$4,336.42 | Price 0.57 | Shares 7,648
Buy 17 Nov 2022
Value US$2,619.11 | Price 0.54 | Shares 4,852
Buy 14 Nov 2022
Value US$27,825.00 | Price 0.53 | Shares 52,500
Buy 30 Nov 2020
Value US$500,004.00 | Price 4.75 | Shares 105,264
Buy 30 Nov 2020
Value US$250,002.00 | Price 4.75 | Shares 52,632
Buy 30 Nov 2020
Value US$250,002.00 | Price 4.75 | Shares 52,632
Buy 30 Nov 2020
Value US$100,001.75 | Price 4.75 | Shares 21,053
Buy 30 Nov 2020
Value US$100,001.75 | Price 4.75 | Shares 21,053
Buy 30 Nov 2020
Value US$100,225.00 | Price 4.75 | Shares 21,100
Buy 7 Dec 2018
Value US$520,000.00 | Price 0.50 | Shares 1,040,000
Buy 7 Dec 2018
Value US$630,000.00 | Price 0.50 | Shares 1,260,000
Buy 7 Dec 2018
Value US$50,000.00 | Price 0.50 | Shares 100,000
Buy 7 Dec 2018
Value US$50,000.00 | Price 0.50 | Shares 100,000
Buy 11 Jan 2017
Value US$59,327.80 | Price 0.06 | Shares 1,005,556
Buy 19 Feb 2016
Value US$3,000.00 | Price 0.30 | Shares 10,000
Buy 17 Feb 2016
Value US$12,963.00 | Price 0.30 | Shares 43,500
Buy 4 Feb 2016
Value US$625.00 | Price 0.25 | Shares 2,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-10-05 2023-10-03 B Purchase
0.8
van der Baan Bastiaan Jeroen

President and CEO

Executive Director
37,939 +43.6%
452.20
US$1,019,665 		37,939 +43.6% 452.20 US$1,019,665
2023-01-04 2022-12-30 B Purchase
0.8
van der Baan Bastiaan Jeroen
Non-Executive Director
14,771 -18.2%
390.08
US$4,387,822 		14,771 -18.2% 390.08 US$4,387,822
2022-12-16 2022-12-15 B Purchase
3.0
Bernards Rene
Non-Executive Director
9,834 +34.0%
433.57
US$2,552,631 		9,834 +34.0% 433.57 US$2,552,631
2022-12-13 2022-12-12 B Purchase
3.0
Bernards Rene
Non-Executive Director
10,000 +8.0%
0.61
US$6,100 		10,000 +8.0% 0.61 US$6,100
2022-11-23 2022-11-22 B Purchase
2.7
FORMAN ERIC

Vice President and COO

Officer
2,484 +2.5%
0.56
US$1,391 		2,484 +2.5% 0.56 US$1,391
2022-11-23 2022-11-21 B Purchase
2.7
FORMAN ERIC

Vice President and COO

Officer
1,457 +1.5%
0.56
US$816 		1,457 +1.5% 0.56 US$816
2022-11-22 2022-11-21 B Purchase
2.4
Brown Regina
Non-Executive Director
2,600 +70.3%
0.58
US$1,508 		2,600 +70.3% 0.58 US$1,508
2022-11-22 2022-11-21 B Purchase
2.4
Brown Regina
Non-Executive Director
2,400 +184.6%
0.57
US$1,368 		2,400 +184.6% 0.57 US$1,368
2022-11-21 2022-11-18 B Purchase
2.7
FORMAN ERIC

Vice President and COO

Officer
6,059 +6.6%
0.56
US$3,389 		6,059 +6.6% 0.56 US$3,389
2022-11-21 2022-11-18 B Purchase
2.7
FORMAN ERIC

Vice President and COO

Officer
2,500 +2.8%
0.56
US$1,400 		2,500 +2.8% 0.56 US$1,400
2022-11-21 2022-11-18 B Purchase
2.7
FORMAN ERIC

Vice President and COO

Officer
7,648 +9.3%
0.57
US$4,336 		7,648 +9.3% 0.57 US$4,336
2022-11-21 2022-11-17 B Purchase
2.7
FORMAN ERIC

Vice President and COO

Officer
4,852 +6.3%
0.54
US$2,619 		4,852 +6.3% 0.54 US$2,619
2022-11-15 2022-11-14 B Purchase
3.0
Bernards Rene
Non-Executive Director
52,500 +72.4%
0.53
US$27,825 		52,500 +72.4% 0.53 US$27,825
2020-12-07 2020-11-30 B Purchase
Schwartzberg Gil
Large shareholder
105,264 +73.9%
4.75
US$500,004 		105,264 +73.9% 4.75 US$500,004
2020-12-04 2020-11-30 B Purchase
Yen Yun
Non-Executive Director
52,632 +inf%
4.75
US$250,002 		52,632 +inf% 4.75 US$250,002
2020-12-03 2020-11-30 B Purchase
2.6
GREENBERG ROBERT
Large shareholder
52,632 +5.6%
4.75
US$250,002 		52,632 +5.6% 4.75 US$250,002
2020-12-03 2020-11-30 B Purchase
Forman Stephen J.
Non-Executive Director
21,053 +126.3%
4.75
US$100,002 		21,053 +126.3% 4.75 US$100,002
2020-12-03 2020-11-30 B Purchase
Palmedo Philip F
Non-Executive Director
21,053 +191.3%
4.75
US$100,002 		21,053 +191.3% 4.75 US$100,002
2020-12-02 2020-11-30 B Purchase
Kovach John S

President and CEO

Executive Director Large shareholder
21,100 +1.4%
4.75
US$100,225 		21,100 +1.4% 4.75 US$100,225
2018-12-11 2018-12-07 B Purchase Schwartzberg Gil Large shareholder
1,040,000 +121.6%
0.50
US$520,000 		1,040,000 +121.6% 0.50 US$520,000
2018-12-11 2018-12-07 B Purchase Riggs Arthur Large shareholder
1,260,000 +26.0%
0.50
US$630,000 		1,260,000 +26.0% 0.50 US$630,000
2018-12-11 2018-12-07 B Purchase Forman Stephen J. Non-Executive Director
100,000 +inf%
0.50
US$50,000 		100,000 +inf% 0.50 US$50,000
2018-12-11 2018-12-07 B Purchase Palmedo Philip F Non-Executive Director
100,000 +10.0%
0.50
US$50,000 		100,000 +10.0% 0.50 US$50,000
2017-01-12 2017-01-11 B Purchase Schwartzberg Gil Large shareholder
1,005,556 +12.4%
0.06
US$59,328 		1,005,556 +12.4% 0.06 US$59,328
2016-02-19 2016-02-19 B Purchase FORMAN ERIC Large shareholder
10,000 +11.1%
0.30
US$3,000 		10,000 +11.1% 0.30 US$3,000
2016-02-19 2016-02-17 B Purchase FORMAN ERIC Large shareholder
43,500 +93.5%
0.30
US$12,963 		43,500 +93.5% 0.30 US$12,963
2016-02-04 2016-02-04 B Purchase FORMAN ERIC Large shareholder
2,500 +5.7%
0.25
US$625 		2,500 +5.7% 0.25 US$625
Explore more

More insider trading research around Lixte Biotechnology Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America